English

POLYDEX PHARMACEUTICALS LTD/BAHAMAS

EDGAR

Annual report (10-K) · filed 2010-05-03

66 filing records in this dataset, filed from 1996-06-14 to 2010-05-03. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.06 million USD

2010-01-31 · USD

Exact inputs and evidence

Revenue: 4481174 USD Source
Revenue: 3416736 USD Source

Operating cash flow

-141 thousand USD

2010-01-31 · USD

Exact inputs and evidence

Operating Cash Flow: -589723 USD Source
Operating Cash Flow: -449093 USD Source

Free cash flow

-157 thousand USD

2010-01-31 · USD

Exact inputs and evidence

Operating Cash Flow: -589723 USD Source
Operating Cash Flow: -449093 USD Source
Capital Expenditure: 68327 USD Source
Capital Expenditure: 52110 USD Source

Cash and cash equivalents: 6.94 thousand USD 2010-01-31 Source
Exact value

6936 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.48 million USD

2009-02-01 – 2010-01-31

Exact inputs and evidence

Revenue: 1030161 USD · 2009-02-01 – 2009-04-30 Source
Revenue: 1232799 USD · 2009-05-01 – 2009-07-31 Source
Revenue: 1153776 USD · 2009-08-01 – 2009-10-31 Source
Revenue: 4481174 USD · 2009-02-01 – 2010-01-31 Source
Revenue: 3416736 USD · 2009-02-01 – 2009-10-31 Source

Net income

-2.14 million USD

2009-02-01 – 2010-01-31

Exact inputs and evidence

Net income: -53727 USD · 2009-02-01 – 2009-04-30 Source
Net income: -557629 USD · 2009-02-01 – 2009-07-31 Source
Net income: -53727 USD · 2009-02-01 – 2009-04-30 Source
Net income: -216442 USD · 2009-08-01 – 2009-10-31 Source
Net income: -2144735 USD · 2009-02-01 – 2010-01-31 Source
Net income: -774071 USD · 2009-02-01 – 2009-10-31 Source

Operating cash flow

-590 thousand USD

2009-02-01 – 2010-01-31

Exact inputs and evidence

Operating cash flow: -225796 USD · 2009-02-01 – 2009-04-30 Source
Operating cash flow: -354209 USD · 2009-02-01 – 2009-07-31 Source
Operating cash flow: -225796 USD · 2009-02-01 – 2009-04-30 Source
Operating cash flow: -449093 USD · 2009-02-01 – 2009-10-31 Source
Operating cash flow: -354209 USD · 2009-02-01 – 2009-07-31 Source
Operating cash flow: -589723 USD · 2009-02-01 – 2010-01-31 Source
Operating cash flow: -449093 USD · 2009-02-01 – 2009-10-31 Source

Capital expenditure

68.3 thousand USD

2009-02-01 – 2010-01-31

Exact inputs and evidence

Capital expenditure: 20936 USD · 2009-02-01 – 2009-04-30 Source
Capital expenditure: 43224 USD · 2009-02-01 – 2009-07-31 Source
Capital expenditure: 20936 USD · 2009-02-01 – 2009-04-30 Source
Capital expenditure: 52110 USD · 2009-02-01 – 2009-10-31 Source
Capital expenditure: 43224 USD · 2009-02-01 – 2009-07-31 Source
Capital expenditure: 68327 USD · 2009-02-01 – 2010-01-31 Source
Capital expenditure: 52110 USD · 2009-02-01 – 2009-10-31 Source

Free cash flow

-658 thousand USD

2009-02-01 – 2010-01-31

Exact inputs and evidence

Operating cash flow: -225796 USD · 2009-02-01 – 2009-04-30 Source
Operating cash flow: -354209 USD · 2009-02-01 – 2009-07-31 Source
Operating cash flow: -225796 USD · 2009-02-01 – 2009-04-30 Source
Operating cash flow: -449093 USD · 2009-02-01 – 2009-10-31 Source
Operating cash flow: -354209 USD · 2009-02-01 – 2009-07-31 Source
Operating cash flow: -589723 USD · 2009-02-01 – 2010-01-31 Source
Operating cash flow: -449093 USD · 2009-02-01 – 2009-10-31 Source
Capital expenditure: 20936 USD · 2009-02-01 – 2009-04-30 Source
Capital expenditure: 43224 USD · 2009-02-01 – 2009-07-31 Source
Capital expenditure: 20936 USD · 2009-02-01 – 2009-04-30 Source
Capital expenditure: 52110 USD · 2009-02-01 – 2009-10-31 Source
Capital expenditure: 43224 USD · 2009-02-01 – 2009-07-31 Source
Capital expenditure: 68327 USD · 2009-02-01 – 2010-01-31 Source
Capital expenditure: 52110 USD · 2009-02-01 – 2009-10-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-05-03.

Financial data available through: 2010-01-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2010-01-31
operating income: No compatible figures in this window
Net income: 5 of 11 periods available· newest 2010-01-31
Operating cash flow: 6 of 11 periods available· newest 2010-01-31
Capital expenditure: 4 of 11 periods available· newest 2010-01-31
assets: No compatible figures in this window
Total liabilities: 6 of 11 periods available· newest 2010-01-31
Current assets: 6 of 11 periods available· newest 2010-01-31
Current liabilities: 6 of 11 periods available· newest 2010-01-31
Cash and cash equivalents: 6 of 11 periods available· newest 2010-01-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-7.1%

Prior period

USD 4.82 million

2008-02-01 – 2009-01-31
Current period

USD 4.48 million

2009-02-01 – 2010-01-31

Exact inputs and evidence

4481174 − 4824906 = -343732 USD

4824906 USD · 2008-02-01 – 2009-01-31
Inspect prior input Prior source
4481174 USD · 2009-02-01 – 2010-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2010-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Year-over-year change in Revenue: -343732 USD Concept: fundies:Revenue Period: 2009-02-01 to 2010-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4481174 USD (2009-02-01 to 2010-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#8597 Input fundies:Revenue: 4824906 USD (2008-02-01 to 2009-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#8597
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 553,265

Prior period

−USD 1.59 million

2008-02-01 – 2009-01-31
Current period

−USD 2.14 million

2009-02-01 – 2010-01-31

Exact inputs and evidence

-2144735 − -1591470 = -553265 USD

-1591470 USD · 2008-02-01 – 2009-01-31
Inspect prior input Prior source
-2144735 USD · 2009-02-01 – 2010-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2010-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Year-over-year change in Net income: -553265 USD Concept: fundies:NetIncome Period: 2009-02-01 to 2010-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -2144735 USD (2009-02-01 to 2010-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9438 Input fundies:NetIncome: -1591470 USD (2008-02-01 to 2009-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9438
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 338,595

Prior period

−USD 251,128

2008-02-01 – 2009-01-31
Current period

−USD 589,723

2009-02-01 – 2010-01-31

Exact inputs and evidence

-589723 − -251128 = -338595 USD

-251128 USD · 2008-02-01 – 2009-01-31
Inspect prior input Prior source
-589723 USD · 2009-02-01 – 2010-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2010-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Year-over-year change in Operating cash flow: -338595 USD Concept: fundies:OperatingCashFlow Period: 2009-02-01 to 2010-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -589723 USD (2009-02-01 to 2010-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9678 Input fundies:OperatingCashFlow: -251128 USD (2008-02-01 to 2009-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9678
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+21.1%

Prior period

USD 56,401

2008-02-01 – 2009-01-31
Current period

USD 68,327

2009-02-01 – 2010-01-31

Exact inputs and evidence

68327 − 56401 = 11926 USD

56401 USD · 2008-02-01 – 2009-01-31
Inspect prior input Prior source
68327 USD · 2009-02-01 – 2010-01-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2010-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Year-over-year change in Capital expenditure: 11926 USD Concept: fundies:CapitalExpenditure Period: 2009-02-01 to 2010-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 68327 USD (2009-02-01 to 2010-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9728 Input fundies:CapitalExpenditure: 56401 USD (2008-02-01 to 2009-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9728
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2009-02-01 – 2010-01-31

Revenue USD 4.48 million 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 2.14 million −48% of revenue

Cash

Operating cash flow −USD 589,723 −13% of revenue
Capital expenditure USD 68,327 1.5% of revenue
Free cash flow Derived −USD 658,050 −15% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Not shown: operating income or net income is not reported.
2006 Not shown: operating income or net income is not reported.
2007 Not shown: operating income or net income is not reported.
2008 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.
2010 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2004-02-01 – 2005-01-31	6372359	Unavailable	Unavailable	Unavailable	Unavailable	Unavailable	Source 2004-02-01 – 2005-01-31: 6372359 USD Inspect Revenue Open source 2004-02-01 – 2005-01-31: -310351 USD Inspect Operating Cash Flow Open source
2006 2005-02-01 – 2006-01-31	5265209	Unavailable	Unavailable	Unavailable	-1489053	Unavailable	Source 2005-02-01 – 2006-01-31: 5265209 USD Inspect Revenue Open source 2005-02-01 – 2006-01-31: -1489053 USD Inspect Net Income Open source 2005-02-01 – 2006-01-31: -425185 USD Inspect Operating Cash Flow Open source
2007 2006-02-01 – 2007-01-31	6499287	Unavailable	Unavailable	Unavailable	-260623	-1058422 Derived	Source 2006-02-01 – 2007-01-31: 6499287 USD Inspect Revenue Open source 2006-02-01 – 2007-01-31: -260623 USD Inspect Net Income Open source 2006-02-01 – 2007-01-31: 666018 USD Inspect Operating Cash Flow Open source 2006-02-01 – 2007-01-31: 1724440 USD Inspect Capital Expenditure Open source
2008 2007-02-01 – 2008-01-31	5734858	Unavailable	Unavailable	Unavailable	-885211	-1784765 Derived	Source 2007-02-01 – 2008-01-31: 5734858 USD Inspect Revenue Open source 2007-02-01 – 2008-01-31: -885211 USD Inspect Net Income Open source 2007-02-01 – 2008-01-31: -297899 USD Inspect Operating Cash Flow Open source 2007-02-01 – 2008-01-31: 1486866 USD Inspect Capital Expenditure Open source
2009 2008-02-01 – 2009-01-31	4824906	Unavailable	Unavailable	Unavailable	-1591470	-307529 Derived	Source 2008-02-01 – 2009-01-31: 4824906 USD Inspect Revenue Open source 2008-02-01 – 2009-01-31: -1591470 USD Inspect Net Income Open source 2008-02-01 – 2009-01-31: -251128 USD Inspect Operating Cash Flow Open source 2008-02-01 – 2009-01-31: 56401 USD Inspect Capital Expenditure Open source
2010 2009-02-01 – 2010-01-31	4481174	Unavailable	Unavailable	Unavailable	-2144735	-658050 Derived	Source 2009-02-01 – 2010-01-31: 4481174 USD Inspect Revenue Open source 2009-02-01 – 2010-01-31: -2144735 USD Inspect Net Income Open source 2009-02-01 – 2010-01-31: -589723 USD Inspect Operating Cash Flow Open source 2009-02-01 – 2010-01-31: 68327 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.5M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-01-31	Revenue	6372359	Revenue: 6372359 Open source
20062006-01-31	Revenue	5265209	Revenue: 5265209 Open source
20072007-01-31	Revenue	6499287	Revenue: 6499287 Open source
20082008-01-31	Revenue	5734858	Revenue: 5734858 Open source
20092009-01-31	Revenue	4824906	Revenue: 4824906 Open source
20102010-01-31	Revenue	4481174	Revenue: 4481174 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-7.1% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-01-31	Year over year	No prior comparable period	Revenue: 6372359 Open source
20062006-01-31	Year over year	-17.4%	Revenue: 5265209 Open source Revenue: 6372359 Open source
20072007-01-31	Year over year	23.4%	Revenue: 6499287 Open source Revenue: 5265209 Open source
20082008-01-31	Year over year	-11.8%	Revenue: 5734858 Open source Revenue: 6499287 Open source
20092009-01-31	Year over year	-15.9%	Revenue: 4824906 Open source Revenue: 5734858 Open source
20102010-01-31	Year over year	-7.1%	Revenue: 4481174 Open source Revenue: 4824906 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -47.9% 2010

Free cash flow margin -14.7% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2005-01-31	Operating margin	Not reported	Revenue: 6372359 Open source
2006-01-31	Operating margin	Not reported	Revenue: 5265209 Open source
2007-01-31	Operating margin	Not reported	Revenue: 6499287 Open source
2008-01-31	Operating margin	Not reported	Revenue: 5734858 Open source
2009-01-31	Operating margin	Not reported	Revenue: 4824906 Open source
2010-01-31	Operating margin	Not reported	Revenue: 4481174 Open source
2005-01-31	Net margin	Not reported	Revenue: 6372359 Open source
20062006-01-31	Net margin	-28.3%	Net Income: -1489053 Open source Revenue: 5265209 Open source
20072007-01-31	Net margin	-4%	Net Income: -260623 Open source Revenue: 6499287 Open source
20082008-01-31	Net margin	-15.4%	Net Income: -885211 Open source Revenue: 5734858 Open source
20092009-01-31	Net margin	-33%	Net Income: -1591470 Open source Revenue: 4824906 Open source
20102010-01-31	Net margin	-47.9%	Net Income: -2144735 Open source Revenue: 4481174 Open source
20052005-01-31	Free cash flow margin	Not reported	Revenue: 6372359 Open source Operating Cash Flow: -310351 Open source
20062006-01-31	Free cash flow margin	Not reported	Revenue: 5265209 Open source Operating Cash Flow: -425185 Open source
20072007-01-31	Free cash flow margin	-16.3%	Revenue: 6499287 Open source Operating Cash Flow: 666018 Open source Capital Expenditure: 1724440 Open source
20082008-01-31	Free cash flow margin	-31.1%	Revenue: 5734858 Open source Operating Cash Flow: -297899 Open source Capital Expenditure: 1486866 Open source
20092009-01-31	Free cash flow margin	-6.4%	Revenue: 4824906 Open source Operating Cash Flow: -251128 Open source Capital Expenditure: 56401 Open source
20102010-01-31	Free cash flow margin	-14.7%	Revenue: 4481174 Open source Operating Cash Flow: -589723 Open source Capital Expenditure: 68327 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -589.7K 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-01-31	Operating cash flow	-310351	Operating Cash Flow: -310351 Open source
20062006-01-31	Operating cash flow	-425185	Operating Cash Flow: -425185 Open source
20072007-01-31	Operating cash flow	666018	Operating Cash Flow: 666018 Open source
20082008-01-31	Operating cash flow	-297899	Operating Cash Flow: -297899 Open source
20092009-01-31	Operating cash flow	-251128	Operating Cash Flow: -251128 Open source
20102010-01-31	Operating cash flow	-589723	Operating Cash Flow: -589723 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -658.1K 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-01-31	Free cash flow	Unavailable	Operating Cash Flow: -310351 Open source
20062006-01-31	Free cash flow	Unavailable	Operating Cash Flow: -425185 Open source
20072007-01-31	Free cash flow	-1058422	Operating Cash Flow: 666018 Open source Capital Expenditure: 1724440 Open source
20082008-01-31	Free cash flow	-1784765	Operating Cash Flow: -297899 Open source Capital Expenditure: 1486866 Open source
20092009-01-31	Free cash flow	-307529	Operating Cash Flow: -251128 Open source Capital Expenditure: 56401 Open source
20102010-01-31	Free cash flow	-658050	Operating Cash Flow: -589723 Open source Capital Expenditure: 68327 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20052005-01-31	Liabilities / assets	Not reported	Total Liabilities: 2260984 Open source
20062006-01-31	Liabilities / assets	Not reported	Total Liabilities: 2132383 Open source
20072007-01-31	Liabilities / assets	Not reported	Total Liabilities: 2768984 Open source
20082008-01-31	Liabilities / assets	Not reported	Total Liabilities: 2079004 Open source
20092009-01-31	Liabilities / assets	Not reported	Total Liabilities: 1511593 Open source
20102010-01-31	Liabilities / assets	Not reported	Total Liabilities: 2277346 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.26× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-01-31	Current assets / current liabilities	3.83×	Current Assets: 4997264 Open source Current Liabilities: 1305846 Open source
20062006-01-31	Current assets / current liabilities	2.76×	Current Assets: 3436588 Open source Current Liabilities: 1246267 Open source
20072007-01-31	Current assets / current liabilities	2.5×	Current Assets: 3963818 Open source Current Liabilities: 1588382 Open source
20082008-01-31	Current assets / current liabilities	3.43×	Current Assets: 3392241 Open source Current Liabilities: 989199 Open source
20092009-01-31	Current assets / current liabilities	3.19×	Current Assets: 1981016 Open source Current Liabilities: 621070 Open source
20102010-01-31	Current assets / current liabilities	1.26×	Current Assets: 2154316 Open source Current Liabilities: 1710401 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2004-02-01 – 2005-01-31	Unavailable Not reported for this period.	−USD 310,351 Exact value Exact value: -310351 USD 2004-02-01 – 2005-01-31: -310351 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2005-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Operating Cash Flow: -310351 USD Concept: fundies:OperatingCashFlow Period: 2004-02-01 to 2005-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3AOperatingCashFlow&period=2005-01-31&surface=latest&period_type=duration&start=2004-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -310351 USD (2004-02-01 to 2005-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001144204-07-021330.txt#10243 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2006 2005-02-01 – 2006-01-31	−USD 1.49 million Exact value Exact value: -1489053 USD 2005-02-01 – 2006-01-31: -1489053 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2006-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Net Income: -1489053 USD Concept: fundies:NetIncome Period: 2005-02-01 to 2006-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3ANetIncome&period=2006-01-31&surface=latest&period_type=duration&start=2005-02-01&unit=USD&dimensions= Input fundies:NetIncome: -1489053 USD (2005-02-01 to 2006-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-08-000873.txt#4781 The citation records this snapshot. The page link may show a newer release later.	−USD 425,185 Exact value Exact value: -425185 USD 2005-02-01 – 2006-01-31: -425185 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2006-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Operating Cash Flow: -425185 USD Concept: fundies:OperatingCashFlow Period: 2005-02-01 to 2006-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3AOperatingCashFlow&period=2006-01-31&surface=latest&period_type=duration&start=2005-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -425185 USD (2005-02-01 to 2006-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-08-000873.txt#4918 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2007 2006-02-01 – 2007-01-31	−USD 260,623 Exact value Exact value: -260623 USD 2006-02-01 – 2007-01-31: -260623 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2007-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Net Income: -260623 USD Concept: fundies:NetIncome Period: 2006-02-01 to 2007-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3ANetIncome&period=2007-01-31&surface=latest&period_type=duration&start=2006-02-01&unit=USD&dimensions= Input fundies:NetIncome: -260623 USD (2006-02-01 to 2007-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-09-000758.txt#5218 The citation records this snapshot. The page link may show a newer release later.	USD 666,018 Exact value Exact value: 666018 USD 2006-02-01 – 2007-01-31: 666018 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2007-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Operating Cash Flow: 666018 USD Concept: fundies:OperatingCashFlow Period: 2006-02-01 to 2007-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3AOperatingCashFlow&period=2007-01-31&surface=latest&period_type=duration&start=2006-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 666018 USD (2006-02-01 to 2007-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-09-000758.txt#5377 The citation records this snapshot. The page link may show a newer release later.	USD 1.72 million Exact value Exact value: 1724440 USD 2006-02-01 – 2007-01-31: 1724440 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2007-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Capital Expenditure: 1724440 USD Concept: fundies:CapitalExpenditure Period: 2006-02-01 to 2007-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3ACapitalExpenditure&period=2007-01-31&surface=latest&period_type=duration&start=2006-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1724440 USD (2006-02-01 to 2007-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-09-000758.txt#5418 The citation records this snapshot. The page link may show a newer release later.	−USD 1.06 million Calculation and evidence 666018 − 1724440 USD Exact free cash flow: -1058422 USD 2006-02-01 – 2007-01-31: 666018 USD · Inspect Operating Cash Flow · Source 2006-02-01 – 2007-01-31: 1724440 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2007-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Free cash flow: -1058422 USD Concept: free-cash-flow Period: 2006-02-01 to 2007-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 666018 USD (2006-02-01 to 2007-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-09-000758.txt#5377 Input fundies:CapitalExpenditure: 1724440 USD (2006-02-01 to 2007-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-09-000758.txt#5418 The citation records this snapshot. The page link may show a newer release later.
2008 2007-02-01 – 2008-01-31	−USD 885,211 Exact value Exact value: -885211 USD 2007-02-01 – 2008-01-31: -885211 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2008-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Net Income: -885211 USD Concept: fundies:NetIncome Period: 2007-02-01 to 2008-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3ANetIncome&period=2008-01-31&surface=latest&period_type=duration&start=2007-02-01&unit=USD&dimensions= Input fundies:NetIncome: -885211 USD (2007-02-01 to 2008-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9438 The citation records this snapshot. The page link may show a newer release later.	−USD 297,899 Exact value Exact value: -297899 USD 2007-02-01 – 2008-01-31: -297899 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2008-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Operating Cash Flow: -297899 USD Concept: fundies:OperatingCashFlow Period: 2007-02-01 to 2008-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3AOperatingCashFlow&period=2008-01-31&surface=latest&period_type=duration&start=2007-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -297899 USD (2007-02-01 to 2008-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9678 The citation records this snapshot. The page link may show a newer release later.	USD 1.49 million Exact value Exact value: 1486866 USD 2007-02-01 – 2008-01-31: 1486866 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2008-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Capital Expenditure: 1486866 USD Concept: fundies:CapitalExpenditure Period: 2007-02-01 to 2008-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3ACapitalExpenditure&period=2008-01-31&surface=latest&period_type=duration&start=2007-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1486866 USD (2007-02-01 to 2008-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9728 The citation records this snapshot. The page link may show a newer release later.	−USD 1.78 million Calculation and evidence -297899 − 1486866 USD Exact free cash flow: -1784765 USD 2007-02-01 – 2008-01-31: -297899 USD · Inspect Operating Cash Flow · Source 2007-02-01 – 2008-01-31: 1486866 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2008-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Free cash flow: -1784765 USD Concept: free-cash-flow Period: 2007-02-01 to 2008-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -297899 USD (2007-02-01 to 2008-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9678 Input fundies:CapitalExpenditure: 1486866 USD (2007-02-01 to 2008-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9728 The citation records this snapshot. The page link may show a newer release later.
2009 2008-02-01 – 2009-01-31	−USD 1.59 million Exact value Exact value: -1591470 USD 2008-02-01 – 2009-01-31: -1591470 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2009-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Net Income: -1591470 USD Concept: fundies:NetIncome Period: 2008-02-01 to 2009-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3ANetIncome&period=2009-01-31&surface=latest&period_type=duration&start=2008-02-01&unit=USD&dimensions= Input fundies:NetIncome: -1591470 USD (2008-02-01 to 2009-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9438 The citation records this snapshot. The page link may show a newer release later.	−USD 251,128 Exact value Exact value: -251128 USD 2008-02-01 – 2009-01-31: -251128 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2009-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Operating Cash Flow: -251128 USD Concept: fundies:OperatingCashFlow Period: 2008-02-01 to 2009-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3AOperatingCashFlow&period=2009-01-31&surface=latest&period_type=duration&start=2008-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -251128 USD (2008-02-01 to 2009-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9678 The citation records this snapshot. The page link may show a newer release later.	USD 56,401 Exact value Exact value: 56401 USD 2008-02-01 – 2009-01-31: 56401 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2009-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Capital Expenditure: 56401 USD Concept: fundies:CapitalExpenditure Period: 2008-02-01 to 2009-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3ACapitalExpenditure&period=2009-01-31&surface=latest&period_type=duration&start=2008-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 56401 USD (2008-02-01 to 2009-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9728 The citation records this snapshot. The page link may show a newer release later.	−USD 307,529 Calculation and evidence -251128 − 56401 USD Exact free cash flow: -307529 USD 2008-02-01 – 2009-01-31: -251128 USD · Inspect Operating Cash Flow · Source 2008-02-01 – 2009-01-31: 56401 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2009-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Free cash flow: -307529 USD Concept: free-cash-flow Period: 2008-02-01 to 2009-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -251128 USD (2008-02-01 to 2009-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9678 Input fundies:CapitalExpenditure: 56401 USD (2008-02-01 to 2009-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9728 The citation records this snapshot. The page link may show a newer release later.
2010 2009-02-01 – 2010-01-31	−USD 2.14 million Exact value Exact value: -2144735 USD 2009-02-01 – 2010-01-31: -2144735 USD Inspect Net Income Open source Share or cite Citation for Net Income · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2010-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Net Income: -2144735 USD Concept: fundies:NetIncome Period: 2009-02-01 to 2010-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3ANetIncome&period=2010-01-31&surface=latest&period_type=duration&start=2009-02-01&unit=USD&dimensions= Input fundies:NetIncome: -2144735 USD (2009-02-01 to 2010-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9438 The citation records this snapshot. The page link may show a newer release later.	−USD 589,723 Exact value Exact value: -589723 USD 2009-02-01 – 2010-01-31: -589723 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2010-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Operating Cash Flow: -589723 USD Concept: fundies:OperatingCashFlow Period: 2009-02-01 to 2010-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3AOperatingCashFlow&period=2010-01-31&surface=latest&period_type=duration&start=2009-02-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -589723 USD (2009-02-01 to 2010-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9678 The citation records this snapshot. The page link may show a newer release later.	USD 68,327 Exact value Exact value: 68327 USD 2009-02-01 – 2010-01-31: 68327 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2010-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Capital Expenditure: 68327 USD Concept: fundies:CapitalExpenditure Period: 2009-02-01 to 2010-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158/explain?concept=fundies%3ACapitalExpenditure&period=2010-01-31&surface=latest&period_type=duration&start=2009-02-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 68327 USD (2009-02-01 to 2010-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9728 The citation records this snapshot. The page link may show a newer release later.	−USD 658,050 Calculation and evidence -589723 − 68327 USD Exact free cash flow: -658050 USD 2009-02-01 – 2010-01-31: -589723 USD · Inspect Operating Cash Flow · Source 2009-02-01 – 2010-01-31: 68327 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · POLYDEX PHARMACEUTICALS LTD/BAHAMAS · 2010-01-31 POLYDEX PHARMACEUTICALS LTD/BAHAMAS (edgar:317158) Free cash flow: -658050 USD Concept: free-cash-flow Period: 2009-02-01 to 2010-01-31 Values: Latest reported Published: 2026-11-02T21:43:03Z Snapshot: 9550ebb94f94b977cc80960e2b168352ec4c81c61e5d3f4e3935a0751d1853b3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/317158?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -589723 USD (2009-02-01 to 2010-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9678 Input fundies:CapitalExpenditure: 68327 USD (2009-02-01 to 2010-01-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/317158/0001204459-10-000960.txt#9728 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

66 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000317158, 317158, edgar:317158

POLYDEX PHARMACEUTICALS LTD/BAHAMAS

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2009-02-01 – 2010-01-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation